| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |